| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-28 | Cox Troy | director | Buy | 15,620 | $9.52 | $149K |
| 2026-07-17 | Kroeger Christopher A. | director, officer | Sale | 16,779 | $37.90 | $636K |
| 2026-07-17 | Lillie James Woodruff | officer | Sale | 2,077 | $37.90 | $79K |
| 2026-07-17 | GILLIS JONATHAN | officer | Sale | 600 | $36.51 | $22K |
| 2026-07-17 | GILLIS JONATHAN | officer | Sale | 16,969 | $37.61 | $638K |
| 2026-07-17 | GILLIS JONATHAN | officer | Sale | 900 | $38.17 | $34K |
| 2026-07-17 | Kreitzer Anatol | officer | Sale | 2,833 | $37.05 | $105K |
| 2026-07-17 | Kreitzer Anatol | officer | Sale | 14,140 | $37.70 | $533K |
| 2026-07-17 | Kreitzer Anatol | officer | Sale | 200 | $38.39 | $8K |
| 2026-07-16 | Kroeger Christopher A. | director, officer | Sale | 40,899 | $36.46 | $1.49M |
| 2026-07-16 | Kroeger Christopher A. | director, officer | Sale | 28,091 | $37.26 | $1.05M |
| 2026-07-16 | Kroeger Christopher A. | director, officer | Sale | 92 | $37.96 | $3K |
| 2026-07-16 | Lillie James Woodruff | officer | Sale | 5,009 | $36.45 | $183K |
| 2026-07-16 | Lillie James Woodruff | officer | Sale | 3,526 | $37.26 | $131K |
| 2026-07-16 | Lillie James Woodruff | officer | Sale | 12 | $37.96 | $456 |
| 2026-07-16 | GILLIS JONATHAN | officer | Sale | 6,979 | $36.66 | $256K |
| 2026-07-16 | GILLIS JONATHAN | officer | Sale | 1,476 | $37.44 | $55K |
| 2026-07-16 | Kreitzer Anatol | officer | Sale | 7,464 | $36.66 | $274K |
| 2026-07-16 | Kreitzer Anatol | officer | Sale | 1,592 | $37.44 | $60K |
| 2026-07-15 | Kroeger Christopher A. | director, officer | Sale | 18,950 | $36.00 | $682K |
| 2026-07-15 | Kroeger Christopher A. | director, officer | Sale | 42,738 | $36.99 | $1.58M |
| 2026-07-15 | Kroeger Christopher A. | director, officer | Sale | 90 | $37.54 | $3K |
| 2026-07-15 | Lillie James Woodruff | officer | Sale | 2,238 | $36.00 | $81K |
| 2026-07-15 | Lillie James Woodruff | officer | Sale | 5,393 | $36.99 | $199K |
| 2026-07-15 | Lillie James Woodruff | officer | Sale | 12 | $37.54 | $450 |
| Filed | Form | Filer | Stake | Shares | |
|---|---|---|---|---|---|
| 2026-08-20 | SCHEDULE 13G | Pivotal bioVenture Partners Fund II, L.P. | — | — | view → |
| 2026-08-18 | SCHEDULE 13D/A | Catalyst4, Inc. | — | 27,536,011 | view → |
| 2026-08-03 | SCHEDULE 13D/A | Catalyst4, Inc. | 47.90% | 20,906,689 | view → |
| Filed | Form | Issuer | Stake | Shares | |
|---|---|---|---|---|---|
| 2026-01-23 | SCHEDULE | IO Biotech, Inc. IOBTQ | 3.30% | 2,469,135 | view → |
| 2025-01-16 | SCHEDULE | Galecto, Inc. DMRA | 7.60% | 99,913 | view → |
| 2024-03-18 | SC | SPRUCE BIOSCIENCES, INC. SPRB | — | — | view → |
| 2024-01-02 | SC | Rallybio Corp RLYB | — | — | view → |
| 2023-08-11 | SC | IO Biotech, Inc. IOBTQ | — | — | view → |
| 2023-06-06 | SC | LAVA Therapeutics NV | — | — | view → |
| 2023-02-24 | SC | LAVA Therapeutics NV | — | — | view → |
| 2023-02-21 | SC | SPRUCE BIOSCIENCES, INC. SPRB | — | — | view → |
| 2022-10-24 | SC | Milestone Pharmaceuticals Inc. MIST | — | — | view → |
| 2022-10-03 | SC | LAVA Therapeutics NV | — | — | view → |
| 2022-09-26 | SC | Milestone Pharmaceuticals Inc. MIST | — | — | view → |
| 2022-09-16 | SC | Edgewise Therapeutics, Inc. EWTX | — | — | view → |
| 2022-08-18 | SC | Mirum Pharmaceuticals, Inc. MIRM | — | — | view → |
| 2022-07-15 | SC | Bolt Biotherapeutics, Inc. BOLT | — | — | view → |
| 2022-02-22 | SC | Morphic Holding, Inc. | — | — | view → |
| 2022-01-27 | SC | Reneo Pharmaceuticals, Inc. OKUR | — | — | view → |
| 2021-12-20 | SC | Cyteir Therapeutics, Inc. | — | — | view → |
| 2021-11-22 | SC | SPRUCE BIOSCIENCES, INC. SPRB | — | — | view → |
| 2021-11-22 | SC | Bolt Biotherapeutics, Inc. BOLT | — | — | view → |
| 2021-11-22 | SC | Nkarta, Inc. NKTX | — | — | view → |
Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.
See pricing →